- Home
- KULR vs OSUR Comparison
KULR vs OSUR Comparison
Compare KULR & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KULR
- OSUR
- Stock Information
- Founded
- KULR 2013
- OSUR 2000
- Country
- KULR United States
- OSUR United States
- Employees
- KULR N/A
- OSUR N/A
- Industry
- KULR Electrical Products
- OSUR Medical/Dental Instruments
- Sector
- KULR Technology
- OSUR Health Care
- Exchange
- KULR Nasdaq
- OSUR Nasdaq
- Market Cap
- KULR 275.2M
- OSUR 248.3M
- IPO Year
- KULR N/A
- OSUR 1986
- Fundamental
- Price
- KULR $1.22
- OSUR $2.99
- Analyst Decision
- KULR Strong Buy
- OSUR Hold
- Analyst Count
- KULR 2
- OSUR 2
- Target Price
- KULR $5.00
- OSUR $5.50
- AVG Volume (30 Days)
- KULR 11.6M
- OSUR 764.0K
- Earning Date
- KULR 05-14-2025
- OSUR 05-07-2025
- Dividend Yield
- KULR N/A
- OSUR N/A
- EPS Growth
- KULR N/A
- OSUR N/A
- EPS
- KULR N/A
- OSUR N/A
- Revenue
- KULR $10,737,481.00
- OSUR $185,827,000.00
- Revenue This Year
- KULR $72.05
- OSUR N/A
- Revenue Next Year
- KULR $180.69
- OSUR $7.55
- P/E Ratio
- KULR N/A
- OSUR N/A
- Revenue Growth
- KULR 9.23
- OSUR N/A
- 52 Week Low
- KULR $0.20
- OSUR $2.69
- 52 Week High
- KULR $5.49
- OSUR $5.59
- Technical
- Relative Strength Index (RSI)
- KULR 41.92
- OSUR 40.88
- Support Level
- KULR $1.06
- OSUR $2.87
- Resistance Level
- KULR $1.40
- OSUR $3.03
- Average True Range (ATR)
- KULR 0.13
- OSUR 0.14
- MACD
- KULR 0.01
- OSUR -0.01
- Stochastic Oscillator
- KULR 47.06
- OSUR 24.07
About KULR KULR Technology Group Inc.
KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems; artificial intelligence and Cloud computing; energy storage; and 5G communication technologies.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.